Trials / Completed
CompletedNCT00733954
Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis
A Comparison Between Clobetasol Propionate (Clobex®) Spray and Clobetasol Propionate Ointment With Regard to Efficacy, Safety, Subject Satisfaction and Duration of Response in Moderate to Severe Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is a comparison between Clobetasol Propionate Spray and Clobetasol Propionate Ointment with Regard to Efficacy, Safety, Subject Satisfaction and Duration of Response in Moderate to Severe Stable Plaque Psoriasis. Subjects will be enrolled and randomized into one of two groups: clobetasol propionate Spray for 4 weeks of treatment or clobetasol propionate ointment for 2 weeks of treatment with a 2 week follow-up visit for each group.
Detailed description
Same as above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clobetasol propionate spray | Apply twice daily |
| DRUG | clobetasol propionate ointment | Apply twice daily |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2008-08-13
- Last updated
- 2022-08-23
- Results posted
- 2009-08-20
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00733954. Inclusion in this directory is not an endorsement.